Integra LifeSciences Holdings CorporationIARTNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Percentile
P0
Near historical low
vs 5Y Ago
-0.4x
Contraction
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$-62.90M-352.0%
2024$24.96M-65.8%
2023$73.09M-66.4%
2022$217.38M-17.8%
2021$264.35M+88.9%
2020$139.94M+44.4%
2019$96.90M-20.5%
2018$121.94M+71.7%
2017$71.04M+2.8%
2016$69.08M-